Computer vision AI offers hope in diagnosing, treating skin disorders
By Dipro Chakraborty  |  Jan 17, 2023
Computer vision AI offers hope in diagnosing, treating skin disorders
Image courtesy of and under license from Shutterstock.com
Computer vision AI shows promise in detecting and treating skin cancer, lesions, and other skin disorders, capturing better images of them, more easily distinguishing benign and malignant lesions, and raising the odds of successful treatment. The risk of bias remains, as does the inability to diagnose rare skin conditions, explains Dipro Chakraborty, director of Digital Architecture at AI healthcare firm TurningPoint.

SAN FRANCISCO - Ever since the advent of AlexNet and deep learning took the computer vision world by storm in 2012, opportunists have been looking for ways to implement the technology within the healthcare space. While some look under the surface, be it DICOM international medical imaging information standard images of X-rays, or whole-slide imaging of pathology, others look at surface level issues that might represent more than meets the eye.

The accessibility of smartphones and portable imaging has ushered in a wave of effort in computer vision to examine problems that can be solved with a clear view of the skin. In areas such as skin cancer, wound care - and even infectious diseases - computer vision AI represents a new tool for an old challenge.

Much of the work in detection of skin-based pathophysiology aided by computer vision artificial intelligence (AI) has focused on melanoma, and for good reason. AI systems rely on large quantities of data to train better models and cover edge cases as needed. As cases of melanoma and other skin cancers continue to rise, institutions and researchers across the world have been adeptly curating image datasets to create computer vision systems. AI applications are preliminarily successful at distinguishing between benign and malignant skin lesions.1

These AI systems can often look at more than 60 distinct features to predict disease classification. Thanks to the architecture of deep learning systems, neural net models can absorb these features and tune their weights appropriately to help predict the likelihood of a particular pathophysiology classification. The mean sensitivities of nearly 50 different commercially available technologies for this type of screening hover around 88 percent. Interest in this area has grown exponentially, to the point that international skin imaging competitions were founded in 2016 and have been ongoing ever since, with the aim of enc

The content herein is subject to copyright by The Yuan. All rights reserved. The content of the services is owned or licensed to The Yuan. The copying or storing of any content for anything other than personal use is expressly prohibited without prior written permission from The Yuan, or the copyright holder identified in the copyright notice contained in the content.
Continue reading
Sign up now to read this story for free.
- or -
Continue with Linkedin Continue with Google
Comments
Share your thoughts.
The Yuan wants to hear your voice. We welcome your on-topic commentary, critique, and expertise. All comments are moderated for civility.